Patricia Elizalde

Affiliations: 
 
Google:
"Patricia Elizalde"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Madera S, Izzo F, Chervo MF, et al. (2023) Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer. Cell Death & Disease. 14: 833
Flaqué MCD, Galigniana NM, Béguelin W, et al. (2023) Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy. Breast Cancer Research : Bcr. 25: 133
Proietti CJ, Béguelin W, Díaz Flaqué MC, et al. (2023) Corrigendum to "Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer" [Steroids 76 (2011) 381-392]. Steroids. 200: 109312
Balañá ME, Labriola L, Salatino M, et al. (2023) Correction: Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells. Oncogene. 42: 3087
Bruni S, Mauro FL, Proietti CJ, et al. (2023) Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression. Journal For Immunotherapy of Cancer. 11
Madera S, Izzo F, Chervo MF, et al. (2022) Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer. Cell Death & Disease. 13: 447
Mercogliano MF, Bruni S, Mauro F, et al. (2021) Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy. Cancers. 13
Chervo MF, Cordo Russo RI, Petrillo E, et al. (2020) Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth. Oncogene
Madera S, Chervo MF, Chiauzzi VA, et al. (2020) Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis. Hormones & Cancer
Mercogliano MF, Bruni S, Elizalde PV, et al. (2020) Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer. Frontiers in Oncology. 10: 584
See more...